Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1987 2
1991 1
1993 2
1994 1
1996 2
1998 2
2000 5
2001 1
2002 4
2003 5
2004 1
2005 3
2006 6
2007 6
2008 9
2009 8
2010 4
2011 12
2012 17
2013 28
2014 20
2015 27
2016 25
2017 31
2018 35
2019 42
2020 37
2021 45
2022 38
2023 32
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

390 results

Results by year

Citations

2 articles found by citation matching
Show all

Search results

Filters applied: . Clear all
Page 1
Antiplatelet therapy for aneurysmal subarachnoid haemorrhage.
Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ. Dorhout Mees SM, et al. Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD006184. doi: 10.1002/14651858.CD006184.pub2. Cochrane Database Syst Rev. 2007. PMID: 17943892 Free PMC article. Review.
BACKGROUND: Secondary ischaemia is a frequent cause of poor outcome in patients with aneurysmal subarachnoid haemorrhage (SAH). Besides vasospasm, platelet aggregation seems to play a role in the pathogenesis of secondary ischaemia. Experimental studies have …
BACKGROUND: Secondary ischaemia is a frequent cause of poor outcome in patients with aneurysmal subarachnoid haemorrhage …
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.
Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, del Zoppo GJ, Kumar MA, Peerschke EI, Stiefel MF, Teitelbaum JS, Wartenberg KE, Zerfoss CL. Frontera JA, et al. Neurocrit Care. 2016 Feb;24(1):6-46. doi: 10.1007/s12028-015-0222-x. Neurocrit Care. 2016. PMID: 26714677 Review.
Although antithrombotic-associated intracranial hemorrhage can be devastating, rapid reversal of coagulopathy may help limit hematoma expansion and improve outcomes. ...RESULTS: Utilizing the GRADE methodology, the committee developed recommendations for reversal of vitami …
Although antithrombotic-associated intracranial hemorrhage can be devastating, rapid reversal of coagulopathy may help limit hematoma …
ESO guideline for the management of extracranial and intracranial artery dissection.
Debette S, Mazighi M, Bijlenga P, Pezzini A, Koga M, Bersano A, Kõrv J, Haemmerli J, Canavero I, Tekiela P, Miwa K, J Seiffge D, Schilling S, Lal A, Arnold M, Markus HS, Engelter ST, Majersik JJ. Debette S, et al. Eur Stroke J. 2021 Sep;6(3):XXXIX-LXXXVIII. doi: 10.1177/23969873211046475. Epub 2021 Oct 13. Eur Stroke J. 2021. PMID: 34746432 Free PMC article.
We further recommend early endovascular or surgical intervention for IAD patients with subarachnoid hemorrhage (SAH). Based on evidence from two phase 2 RCTs that have shown no difference between the benefits and risks of anticoagulants versus antiplatelets i …
We further recommend early endovascular or surgical intervention for IAD patients with subarachnoid hemorrhage (SAH). Based on …
Antiplatelet therapy and outcomes after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
Garton ALA, Berger K, Merkler AE, Kamel H, Knopman J, Zhang C, Murthy SB. Garton ALA, et al. Clin Neurol Neurosurg. 2023 Dec;235:108025. doi: 10.1016/j.clineuro.2023.108025. Epub 2023 Oct 26. Clin Neurol Neurosurg. 2023. PMID: 37925994
BACKGROUND: The efficacy of antiplatelet therapy (APT) after aneurysmal subarachnoid hemorrhage (aSAH) remains unclear. ...CONCLUSIONS: APT after aSAH was associated with a modest improvement in functional outcome, but there was no relationship …
BACKGROUND: The efficacy of antiplatelet therapy (APT) after aneurysmal subarachnoid hemorrhage (aSAH) re …
Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: an updated meta-analysis.
Lee KS, Lee C, Dhillon PS, Kirollos R, Nga VDW, Yeo TT, Henkes H, Arthur AS, Yeo LLL, Bhogal P. Lee KS, et al. Neurosurg Rev. 2023 Sep 4;46(1):221. doi: 10.1007/s10143-023-02120-2. Neurosurg Rev. 2023. PMID: 37665377 Free PMC article. Review.
Antiplatelet therapy (AT) may serve to reduce the effects of aneurysmal subarachnoid hemorrhage (aSAH)-induced pro-coagulant state in the cerebral circulation. ...
Antiplatelet therapy (AT) may serve to reduce the effects of aneurysmal subarachnoid hemorrhage (aSAH)-in …
Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome.
Sebök M, Hostettler IC, Keller E, Rautalin IM, Coert BA, Vandertop WP, Post R, Sardeha A, Tjerkstra MA, Regli L, Verbaan D, Germans MR. Sebök M, et al. Int J Stroke. 2022 Jun;17(5):545-552. doi: 10.1177/17474930211035647. Epub 2021 Jul 29. Int J Stroke. 2022. PMID: 34282988 Free PMC article.
BACKGROUND: Literature is inconclusive regarding the association between antiplatelet agents use and outcome after aneurysmal subarachnoid hemorrhage. ...METHODS: Data were collected from prospective databases of two European tertiary reference centers …
BACKGROUND: Literature is inconclusive regarding the association between antiplatelet agents use and outcome after aneurysmal …
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag… See abstract for full author list ➔ Bateman RM, et al. Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6. Crit Care. 2016. PMID: 27885969 Free PMC article.
Zeerleder, N. P. Juffermans P055 - Cessation of a preexisting chronic antiplatelet therapy is associated with increased mortality rates in severe sepsis and septic shock C. ...Kindgen-Milles P188 - Citrate regional anticoagulation for post dilution continuous renal …
Zeerleder, N. P. Juffermans P055 - Cessation of a preexisting chronic antiplatelet therapy is associated with increased mortal …
Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018.
Boulanger JM, Lindsay MP, Gubitz G, Smith EE, Stotts G, Foley N, Bhogal S, Boyle K, Braun L, Goddard T, Heran M, Kanya-Forster N, Lang E, Lavoie P, McClelland M, O'Kelly C, Pageau P, Pettersen J, Purvis H, Shamy M, Tampieri D, vanAdel B, Verbeek R, Blacquiere D, Casaubon L, Ferguson D, Hegedus Y, Jacquin GJ, Kelly M, Kamal N, Linkewich B, Lum C, Mann B, Milot G, Newcommon N, Poirier P, Simpkin W, Snieder E, Trivedi A, Whelan R, Eustace M, Smitko E, Butcher K. Boulanger JM, et al. Int J Stroke. 2018 Dec;13(9):949-984. doi: 10.1177/1747493018786616. Epub 2018 Jul 18. Int J Stroke. 2018. PMID: 30021503 Review.
Other notable changes include the removal of two sections related to the emergency management of intracerebral hemorrhage and subarachnoid hemorrhage. These topics are covered in a new, dedicated module, to be released later this year. The most significant re …
Other notable changes include the removal of two sections related to the emergency management of intracerebral hemorrhage and suba …
Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage.
Darkwah Oppong M, Gembruch O, Pierscianek D, Köhrmann M, Kleinschnitz C, Deuschl C, Mönninghoff C, Kaier K, Forsting M, Sure U, Jabbarli R. Darkwah Oppong M, et al. Neurosurgery. 2019 Dec 1;85(6):827-833. doi: 10.1093/neuros/nyy550. Neurosurgery. 2019. PMID: 30544176
BACKGROUND: Delayed cerebral ischemia (DCI) has a strong impact on outcome of patients with aneurysmal subarachnoid hemorrhage (SAH). Positive effect of antiplatelet therapy on DCI rates has been supposed upon smaller SAH series. ...The individu …
BACKGROUND: Delayed cerebral ischemia (DCI) has a strong impact on outcome of patients with aneurysmal subarachnoid hemorrh …
Impact of pre-ictal antiplatelet therapy use in aneurysmal subarachnoid hemorrhage.
Al-Mufti F, Ogulnick J, Feldstein E, Damodara N, Bravo M, Alshammari H, Dominguez J, Cooper J, Huang KT, Marikunte S, Ali S, Patel V, Khandelwal P, Mayer SA, Amuluru K, Gandhi CD. Al-Mufti F, et al. Clin Neurol Neurosurg. 2021 Dec;211:107022. doi: 10.1016/j.clineuro.2021.107022. Epub 2021 Nov 10. Clin Neurol Neurosurg. 2021. PMID: 34781219
OBJECTIVE: There is limited evidence on the use of antiplatelet therapy (APT) to reduce the risk and morbidity of cerebral aneurysmal rupture. This analysis retrospectively assessed APT use in patients presenting to our institution with aneurysmal s …
OBJECTIVE: There is limited evidence on the use of antiplatelet therapy (APT) to reduce the risk and morbidity of cerebral …
390 results